메뉴 건너뛰기




Volumn 168, Issue 12, 1998, Pages 619-626

Chronic viral hepatitis

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; HEPATITIS VACCINE; LAMIVUDINE; NUCLEOSIDE ANALOG; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN; VIRUS RNA;

EID: 0032526933     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1998.tb141451.x     Document Type: Review
Times cited : (9)

References (31)
  • 1
    • 0021751383 scopus 로고
    • Survival in chronic hepatitis B. An analysis of 379 patients
    • Weissberg JI, Andres LL, Smith CI, et al. Survival in chronic hepatitis B. An analysis of 379 patients. Ann Intern Med 1984; 101: 613-616.
    • (1984) Ann Intern Med , vol.101 , pp. 613-616
    • Weissberg, J.I.1    Andres, L.L.2    Smith, C.I.3
  • 2
    • 0030707941 scopus 로고    scopus 로고
    • Hepatitis B virus infection
    • Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745.
    • (1997) N Engl J Med , vol.337 , pp. 1733-1745
    • Lee, W.M.1
  • 3
    • 0026527586 scopus 로고
    • Acute exacerbations of chronic hepatitis B are accompanied by increased T cell responses to hepatitis core and e antigens
    • Tsai SL, Chen MY, Yang PM, et al. Acute exacerbations of chronic hepatitis B are accompanied by increased T cell responses to hepatitis core and e antigens. J Clin Invest 1992; 89: 87-93.
    • (1992) J Clin Invest , vol.89 , pp. 87-93
    • Tsai, S.L.1    Chen, M.Y.2    Yang, P.M.3
  • 4
    • 0026663085 scopus 로고
    • Hepatitis B-related end-stage liver disease
    • Everhart JE, Hoofnagle J. Hepatitis B-related end-stage liver disease. Gastroenterology 1992; 103: 1692-1694.
    • (1992) Gastroenterology , vol.103 , pp. 1692-1694
    • Everhart, J.E.1    Hoofnagle, J.2
  • 5
    • 0029893146 scopus 로고    scopus 로고
    • Long-term follow-up of HBeAg positive patients treated with interferon alfa for chronic hepatitis B
    • Niederau C, Heintges T, Lange S, et al. Long-term follow-up of HBeAg positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996; 334: 1422-1427.
    • (1996) N Engl J Med , vol.334 , pp. 1422-1427
    • Niederau, C.1    Heintges, T.2    Lange, S.3
  • 6
    • 0028887880 scopus 로고
    • Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: Outcomes and predictors of response
    • Hope RL, Weltman M, Dingley J, et al. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response. Med J Aust 1995; 162: 8-11.
    • (1995) Med J Aust , vol.162 , pp. 8-11
    • Hope, R.L.1    Weltman, M.2    Dingley, J.3
  • 7
    • 0030933395 scopus 로고    scopus 로고
    • Natural history of liver fibrosis progression in patients with chronic hepatitis C
    • Poynard T, Bedossa P, Opolon P, et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-832.
    • (1997) Lancet , vol.349 , pp. 825-832
    • Poynard, T.1    Bedossa, P.2    Opolon, P.3
  • 8
    • 0031041924 scopus 로고    scopus 로고
    • Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
    • Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112: 463-472.
    • (1997) Gastroenterology , vol.112 , pp. 463-472
    • Fattovich, G.1    Giustina, G.2    Degos, F.3
  • 9
    • 17144435206 scopus 로고
    • Hepatitis C: A current perspective
    • Farrell GC. Hepatitis C: a current perspective. Aust Fam Physician 1995; 24: 321-329.
    • (1995) Aust Fam Physician , vol.24 , pp. 321-329
    • Farrell, G.C.1
  • 10
    • 0030928695 scopus 로고    scopus 로고
    • Hepatitis C: The clinical spectrum of disease
    • Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology 1997; 26 (3 Suppl 1): 15S-20S.
    • (1997) Hepatology , vol.26 , Issue.3 SUPPL. 1
    • Hoofnagle, J.H.1
  • 11
    • 0028876341 scopus 로고
    • Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations
    • Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-620.
    • (1995) Ann Intern Med , vol.123 , pp. 615-620
    • Gumber, S.C.1    Chopra, S.2
  • 12
    • 0023784399 scopus 로고
    • Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis
    • Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterotogy 1988; 95: 734-739.
    • (1988) Gastroenterotogy , vol.95 , pp. 734-739
    • Williams, A.L.1    Hoofnagle, J.H.2
  • 13
    • 0026042728 scopus 로고
    • Treatment of chronic hepatitis B
    • Davis GL. Treatment of chronic hepatitis B. Hepatology 1991; 14: 567-569.
    • (1991) Hepatology , vol.14 , pp. 567-569
    • Davis, G.L.1
  • 14
    • 0028836094 scopus 로고
    • Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation
    • Angus PW, Locarnini SA, McCaughan GW, et al. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Hepatology 1995; 21: 14-18.
    • (1995) Hepatology , vol.21 , pp. 14-18
    • Angus, P.W.1    Locarnini, S.A.2    McCaughan, G.W.3
  • 15
    • 0030063669 scopus 로고    scopus 로고
    • Thrombocytopenia associated with hepatitis C viral infection
    • Nagamine T, Ohtuka T, Takehara K, et al. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 1996; 24: 135-140.
    • (1996) J Hepatol , vol.24 , pp. 135-140
    • Nagamine, T.1    Ohtuka, T.2    Takehara, K.3
  • 16
    • 0030046698 scopus 로고    scopus 로고
    • The infected health care provider
    • Gerberding JL. The infected health care provider. N Engl J Med 1996; 334: 594-595.
    • (1996) N Engl J Med , vol.334 , pp. 594-595
    • Gerberding, J.L.1
  • 17
    • 0028894309 scopus 로고
    • Hepatitis induced by traditional Chinese herbs; possible toxic components
    • Kane JA, Kane SP, Jain S. Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut 1995; 36: 146-148.
    • (1995) Gut , vol.36 , pp. 146-148
    • Kane, J.A.1    Kane, S.P.2    Jain, S.3
  • 18
    • 0030917694 scopus 로고    scopus 로고
    • Safety issues in herbal medicine: Implications for the health professions
    • Drew AK, Myers SP. Safety issues in herbal medicine: implications for the health professions. Med J Aust 1997; 166: 538-541.
    • (1997) Med J Aust , vol.166 , pp. 538-541
    • Drew, A.K.1    Myers, S.P.2
  • 19
    • 0027378724 scopus 로고
    • Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis
    • Wong DKH, Cheung AM, O'Rourke K, et al. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993; 119: 312-323.
    • (1993) Ann Intern Med , vol.119 , pp. 312-323
    • Wong, D.K.H.1    Cheung, A.M.2    O'Rourke, K.3
  • 21
    • 0030795953 scopus 로고    scopus 로고
    • Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value
    • Ockenga J, Tillmann HL, Trautwein C, et al. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol 1997; 27: 18-24.
    • (1997) J Hepatol , vol.27 , pp. 18-24
    • Ockenga, J.1    Tillmann, H.L.2    Trautwein, C.3
  • 22
    • 1842291578 scopus 로고    scopus 로고
    • The treatment of chronic viral hepatitis
    • Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336: 347-356.
    • (1997) N Engl J Med , vol.336 , pp. 347-356
    • Hoofnagle, J.H.1    Di Bisceglie, A.M.2
  • 23
    • 0028864271 scopus 로고
    • Interferon alfa-2b for chronic hepatitis C: Effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial
    • Lin R, Roach E, Zimmerman M, et al. Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. J Hepatol 1995; 23: 487-496.
    • (1995) J Hepatol , vol.23 , pp. 487-496
    • Lin, R.1    Roach, E.2    Zimmerman, M.3
  • 24
    • 0029833829 scopus 로고    scopus 로고
    • Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
    • Poynard T, Leroy V, Cohard M, et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 1996; 24: 778-789.
    • (1996) Hepatology , vol.24 , pp. 778-789
    • Poynard, T.1    Leroy, V.2    Cohard, M.3
  • 25
    • 0030886964 scopus 로고    scopus 로고
    • National Institutes of Health Consensus Development Conference Panel Statement: Management of hepatitis C
    • National Institutes of Health Consensus Development Conference Panel Statement: management of hepatitis C. Hepatology 1997; 26 (Suppl 1): 2S-10S.
    • (1997) Hepatology , vol.26 , Issue.1 SUPPL.
  • 26
    • 0030093219 scopus 로고    scopus 로고
    • Virus and host factors are both important determinants of response to interferon treatment among patients with chronic hepatitis C
    • Lin R, Liddle C, Byth K, Farrell GC. Virus and host factors are both important determinants of response to interferon treatment among patients with chronic hepatitis C. J Viral Hepatitis 1996; 3: 85-96.
    • (1996) J Viral Hepatitis , vol.3 , pp. 85-96
    • Lin, R.1    Liddle, C.2    Byth, K.3    Farrell, G.C.4
  • 27
    • 0030039651 scopus 로고    scopus 로고
    • A survey of adverse effects in 11241 patients with chronic viral hepatitis treated with alfa interferon
    • Fattovich G, Giustina G, Favarato S, et al. A survey of adverse effects in 11241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996; 24: 38-47.
    • (1996) J Hepatol , vol.24 , pp. 38-47
    • Fattovich, G.1    Giustina, G.2    Favarato, S.3
  • 28
    • 2642602568 scopus 로고    scopus 로고
    • Recombinant interferon alfa-2b (Intron A) alone or in combination with ribavirin (Rebetol) for retreatment of interferon relapse in chronic hepatitis C
    • submitted
    • Davis GL, Esteban-Mur R, Rustgi V, et al. Recombinant interferon alfa-2b (Intron A) alone or in combination with ribavirin (Rebetol) for retreatment of interferon relapse in chronic hepatitis C. N Engl J Med (submitted).
    • N Engl J Med
    • Davis, G.L.1    Esteban-Mur, R.2    Rustgi, V.3
  • 29
    • 16044367618 scopus 로고    scopus 로고
    • Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
    • Grellier L, Mutimer D, Ahmed M, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348: 1212-1215.
    • (1996) Lancet , vol.348 , pp. 1212-1215
    • Grellier, L.1    Mutimer, D.2    Ahmed, M.3
  • 30
    • 0031009212 scopus 로고    scopus 로고
    • Liver transplantation for hepatitis C-associated cirrhosis in a single Australian centre: Referral patterns and transplant outcomes
    • Levy MT, Chen JJ, McGuinness PH, et al. Liver transplantation for hepatitis C-associated cirrhosis in a single Australian centre: referral patterns and transplant outcomes. J Gastroenterol Hepatol 1997; 12: 453-459.
    • (1997) J Gastroenterol Hepatol , vol.12 , pp. 453-459
    • Levy, M.T.1    Chen, J.J.2    McGuinness, P.H.3
  • 31
    • 0029877783 scopus 로고    scopus 로고
    • Treating small hepatocellular carcinomas
    • Williams R, Rizzi P. Treating small hepatocellular carcinomas. N Engl J Med 1996; 334: 728-729.
    • (1996) N Engl J Med , vol.334 , pp. 728-729
    • Williams, R.1    Rizzi, P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.